Literature DB >> 11456140

Absence of association between serum homocysteine levels and coronary artery disease in south Indian males.

R Deepa1, K Velmurugan, G Saravanan, K Karkuzhali, V Dwarakanath, V Mohan.   

Abstract

BACKGROUND: Asian Indians are reported to have a very high prevalence of premature coronary artery disease. However, traditional risk factors do not explain this excess of coronary artery disease. Elevated levels of homocysteine are reported to be associated with coronary artery disease among Europeans. This study looked at the association of serum homocysteine levels with coronary artery disease in South Indians. METHODS AND
RESULTS: Four groups of patients were studied: Group 1 consisted of healthy nondiabetic subjects without coronary artery disease (n=18): Group 2 consisted of nondiabetic subjects with coronary artery disease (n=21); Group 3 consisted of type 2 diabetic patients without coronary artery disease (n=18) and Group 4 consisted of type 2 diabetic patients with coronary artery disease (n=20). The mean homocysteine value was 12.4+/-3.4 micromol/L in Group 1; 12.6+/-4.6 micromol/L in Group 2; 10.1+/-4.4 micromol/L in Group 3; and 10.4+/-3.9 micromol/ L in Group 4. There was no significant difference in the homocysteine levels between the groups studied. The prevalence of hyperhomocysteinemia, defined as a level of 17.1 micromol/L (the 95th percentile for serum homocysteine in the control group) was not significantly different among the groups.
CONCLUSIONS: Elevated serum homocysteine levels are not associated with coronary artery disease in South Indian male subjects with or without diabetes. However, the results must be interpreted with caution because of the small numbers studied.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11456140

Source DB:  PubMed          Journal:  Indian Heart J        ISSN: 0019-4832


  15 in total

1.  Prothrombotic gene polymorphisms and plasma factors in young North Indian survivors of acute myocardial infarction.

Authors:  Rupinder Kaur Dogra; Reena Das; Jasmina Ahluwalia; Rohit Manoj Kumar; K K Talwar
Journal:  J Thromb Thrombolysis       Date:  2012-08       Impact factor: 2.300

2.  Elevated oxidative stress among coronary artery disease patients on statin therapy: A cross sectional study.

Authors:  Sabitha Palazhy; Prakash Kamath; Damodaran M Vasudevan
Journal:  Indian Heart J       Date:  2015-04-27

Review 3.  Type 2 diabetes and cardiovascular risk in the UK south Asian community.

Authors:  A H Barnett; A N Dixon; S Bellary; M W Hanif; J P O'hare; N T Raymond; S Kumar
Journal:  Diabetologia       Date:  2006-07-18       Impact factor: 10.122

4.  Serum homocysteine in Indian adolescents.

Authors:  Pratima Anand; Shally Awasthi; Abbas Mahdi; Manoj Tiwari; G G Agarwal
Journal:  Indian J Pediatr       Date:  2009-04-16       Impact factor: 1.967

5.  Risk Factors for Coronary Artery Disease in Indians.

Authors:  D S Jaswal; T K Saha; N Aggarwal
Journal:  Med J Armed Forces India       Date:  2011-07-21

6.  Homocysteine status and acute myocardial infarction among Tamilians.

Authors:  T Angeline; Rita Mary Aruna; K Ramadevi; G Mohan; Nirmala Jeyaraj
Journal:  Indian J Clin Biochem       Date:  2005-01

7.  Studies on homocysteine demonstrating its significance as a possible tool for differential diagnosis in occlusive vascular disease.

Authors:  Seema Bhargava; R Parakh; L M Srivastava
Journal:  Indian J Clin Biochem       Date:  2004-01

8.  Raised serum homocysteine levels in patients of coronary artery disease and the effect of vitamin B12 and folate on its concentration.

Authors:  R Abraham; M Joseph John; R Calton; J Dhanoa
Journal:  Indian J Clin Biochem       Date:  2006-03

9.  Risk prediction-Homocysteine in Coronary Heart Disease.

Authors:  Rao B Harish; V Govindaraju; C N Manjunath
Journal:  Indian J Clin Biochem       Date:  2007-03

Review 10.  Genetic epidemiology of coronary artery disease: an Asian Indian perspective.

Authors:  Shanker Jayashree; Maitra Arindam; Kakkar V Vijay
Journal:  J Genet       Date:  2015-09       Impact factor: 1.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.